Medical Diagnostics & Research Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Medical Diagnostics & Research
Quest Diagnostics Inc (DGX) Q1 2024 Earnings Call Transcript Highlights: Key Financial Outcomes and Future Projections
Discover the pivotal financial results and strategic insights from Quest Diagnostics' first quarter of 2024, including revenue growth, EPS guidance, and operational achievements. Apr 24, 2024
GuruFocus Research Medical Diagnostics & Research
XWELL Inc (XWEL) Q4 2023 Earnings Call Transcript Highlights: Strategic Expansions and Cost Optimization Drive Progress
Discover how XWELL Inc's innovative strategies and operational efficiencies are shaping its journey towards profitability and expansion. Apr 19, 2024
GuruFocus Research Medical Diagnostics & Research
OncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and Financial Milestones Amidst Challenges
OncoCyte details reduced burn rate, Bio-Rad partnership, and growth in the transplant market, alongside a significant net loss in Q4 2023. Apr 13, 2024